Hum. Reprod. Advance Access published online on October 16, 2007
Human Reproduction, doi:10.1093/humrep/dem278
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study
1 Service dHormonologie, Hôpital Lapeyronie, CHU Montpellier, 34295 Montpellier cedex 5, France 2 Service dEndocrinologie Pédiatrique, Hôpital Robert Debré, AP-HP, 75935 Paris, France 3 Developmental Endocrinology Research Group, Clinical and Molecular Genetics, UCL Institute of Child Health, University College London, London WC1N 1EH, UK 4 Service de Pédiatrie I, Unité dEndocrinologie, Hôpitaux Universitaires de Strasbourg, 67200 Strasbourg, France 5 Unité dEndocrinologie Pédiatrique (C.S.), Hôpital Arnaud de Villeneuve, CHU Montpellier, 34295 Montpellier, France
6Correspondence address. Tel: +33-467-33-86-96; Fax: +33-467-04-85-73; E-mail: c-sultan{at}chu-montpellier.fr
BACKGROUND: Steroidogenic factor 1 (SF1/AdBP4/FTZF1, NR5A1) is a nuclear receptor transcription factor that plays a key role in regulating adrenal and gonadal development, steroidogenesis and reproduction. Recently, haploinsufficiency of SF1 has been described in several 46,XY individuals with mild gonadal dysgenesis and impaired androgenization, but normal adrenal function, suggesting that dosage-sensitive or domain-specific effects of SF1 action are important in human testicular development and function. Our objective was to investigate whether partial defects in SF1 function might be associated with milder male reproductive phenotypes, such as bilateral anorchia (vanishing testis syndrome) and micropenis.
METHODS: This study involved mutational analysis of NR5A1 in 24 individuals with bilateral anorchia and micropenis from the French Collaborative Anorchia study, as well as in vitro functional studies of SF1-dependent transcriptional activation and computer modeling.
RESULTS: A novel heterozygous missense mutation (V355M) in SF1 was found in one boy with a micropenis and testicular regression syndrome. This non-synonymous change was found to affect a highly conserved amino acid within helix 7 of the ligand-binding domain of SF1. This V355M mutation did not affect stability or nuclear localization, but did result in an
50% reduction in SF1 activity in several different assay systems.
CONCLUSIONS: In conclusion, heterozygous partial loss of function mutations in SF1 may be associated with bilateral anorchia (vanishing testis syndrome) and micropenis in humans.
Key words: SF1/gonadal dysgenesis/vanishing testis syndrome/testicular regression/disorders of sexual development
Partially presented at the 45th ESPE Annual Meeting, Rotterdam, 2006. Abstract in Horm Res 2006;65(Suppl 4):110–111. Submitted on May 8, 2007; resubmitted on June 13, 2007; accepted on June 18, 2007.